Asi Pilin Shuangmi Damo Pian (阿司匹林双嘧达莫片)阿司匹林双嘧达莫片
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 先声药业有限公司Chinese legal name: 先声药业有限公司
主要成分Active Ingredients
- 阿司匹林 双嘧达莫Recorded Chinese composition: 阿司匹林 双嘧达莫
- 阿司匹林aspirin
- 双嘧达莫Shuangmi Damo
药物知识说明
阿司匹林 双嘧达莫是一种在国家药监局注册认定的药品。该药品含有双嘧达莫、阿司匹林-2dcb8c0d等成分。
该药品关联的活性成分包括：双嘧达莫Shuangmi Damo、阿司匹林aspirin。这些成分信息来自国家药监局数据库。
该药品标注的生产企业为：先声药业有限公司Chinese legal name: 先声药业有限公司。
您可以探索含有相同成分的其他药品：双嘧达莫-862c5791成分药品。
本页面内容来自国家药监局数据库，MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 阿司匹林双嘧达莫片) is a medicine registered with the national drug regulatory authority. It contains aspirin and other recorded ingredients as active ingredient(s).
Active ingredients associated with this product: 双嘧达莫Shuangmi Damo, 阿司匹林aspirin.
Manufacturers recorded for this product: 先声药业有限公司Chinese legal name: 先声药业有限公司.
Explore other medicines containing the same ingredient: 双嘧达莫 productsProducts containing this recorded ingredient.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 阿司匹林双嘧达莫片Recorded Chinese name: 阿司匹林双嘧达莫片
- 剂型Dosage form: 片剂Tablets
- 规格Specification: 每片含阿司匹林75mg、双嘧达莫25mgRecorded Chinese composition: 每片含阿司匹林75mg、双嘧达莫25mg
本段仅展示注册/说明书已记录的身份属性，不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
主要成分Ingredients
生产企业Manufacturer
- 先声药业有限公司Chinese legal name: 先声药业有限公司
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字H46020526
关联实体Relationships
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
- 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录（非改写、非AI摘要），非正式英文标签，亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字H46020526
Manufacturer
Chinese legal name: 先声药业有限公司 (domestically manufactured)
Indications
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
Protect from light and keep tightly closed.
Specification
English translation unavailable. The original Chinese source label remains available below.
中文说明书原文Original Chinese source label
批准文号
国药准字H46020526
生产企业
先声药业有限公司(国产)
适应症
用于防治血栓栓塞，降低心肌梗塞、脑血栓的形成以及慢性心绞痛的治疗；也可用于外科手术后的心瓣膜病及人工瓣膜手术后原发性、复发性血栓静脉炎等。
用法用量
遵医嘱服用；常用量一次1-2片，每日2-4次，饭后服用。
不良反应
不良反应少，偶有头痛、眩晕、耳鸣。轻度胃肠道反应和皮疹、尊麻疹，减量或停药后可恢复。
禁忌
1、低血压伴心肌梗塞的患者禁用；
2、严重肝功能损害、低凝血酶原血症、维生素K缺乏和血友病患者禁用。
注意事项
定期检查血小板功能和计数，出现出血性紫斑应停药或减量；个别患者有脱发现象发生，停药后可恢复。
贮藏
遮光、密封保存。
规格
每片含阿司匹林75mg、双嘧达莫25mg
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.